BALVERSA® is an oral prescription medicine used to treat adults who:
Have bladder cancer (urothelial cancer) that has spread or cannot be removed by surgery 
Have a tumor that carries a certain type of abnormal FGFR gene 
Have tried at least one other medicine by mouth or injection (systemic therapy) that did not work or is no longer working- Discuss all of your treatment options with your doctor.
Your doctor will perform a test to check for certain types of abnormal FGFR genes and make sure that BALVERSA® is right for you.
How can I find out if my tumor has an abnormal FGFR gene?
A doctor will send a tissue sample from the tumor to a lab for analysis.
BALVERSA® was studied in people whose tumors had an abnormal FGFR gene
BALVERSA® was studied in a trial with 266 people with advanced bladder cancer who had tried at least 1 immunotherapy medicine. Learn more about the BALVERSA® study.